Lilly obesity-pill trial results find a warmer reception on Wall Street this time aroundBy Mario Cazombo / August 26, 2025 Pharmaceutical giant Eli Lilly said it will now move “with urgency” toward getting regulatory approval for orforglipron.
Book Review: The Financial Restructuring Tool Set August 6, 2025 / Book Reviews, Corporate Finance, Drivers of Value, Economics, Financial Statement Analysis, General
